Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
< Previous
1
2
3
Next >
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
SVB Leerink
Aduhelm
Marc Goodman
From
Benzinga
Following Up on Your Suggestions – September 2022
September 26, 2022
Tickers
DIET
Tags
Impax Laboratories (IPXL)
GlaxoSmithKline (GSK)
Eli Lilly (LLY)
From
Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
August 10, 2022
Tickers
DGX
Tags
Events, Media & Communications
Research, Reports & Publications
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
August 04, 2022
Tickers
CGTX
Tags
Exclusives
Biotech
Market News
From
Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
July 19, 2022
Tags
ProMIS Neurosciences (PMN/TO ARFXF)
Genting Berhad (GEBHY)
INmune Bio (INMB)
From
Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
July 08, 2022
Tickers
ABBV
ALEC
Tags
ALEC
Small Cap
Alzheimer's disease
From
Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
June 13, 2022
Tags
Cassava Sciences (SAVA)
Guest Articles
Alzheimer's Disease
From
Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
Tags
BIIB
Aduhelm
Health Care
From
Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
May 10, 2022
Tags
BACE Inhibitors
Doc Gumshoe
Eisai (ESALY)
From
Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Health Care
Briefs
News
From
Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Tickers
SAVA
Tags
Alzheimer's disease
Market News
Biotech
From
Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
Tags
News
General
Benzinga
From
Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
General
News
Government
From
Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
Tags
Phase 1 Trial
Market News
Biotech
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Biotech
Market News
From
Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Benzinga
News
Briefs
From
Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
Tags
Small Cap
Market News
Biotech
From
Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
Tags
Trading Ideas
Penny Stocks
Alzheimer's disease
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
ESALY
General
From
Benzinga
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
February 15, 2022
Tickers
ACIU
JNJ
Tags
Biotech
Market News
Alzheimer's disease
From
Benzinga
Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report
January 28, 2022
Tickers
LLY
Tags
LLY
Health Care
Alzheimer's disease
From
Benzinga
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
January 26, 2022
Tickers
CRTX
Tags
Movers
Benzinga
Briefs
From
Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
Tickers
DNLI
Tags
Trading Ideas
Alzheimer's Drugs
DNLI
From
Benzinga
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
BIIB
Biotech
Market News
From
Benzinga
Exclusive: Longeveron Kickstarts Its Mid-Stage Alzheimer's Disease Trial
January 05, 2022
Tickers
LGVN
Tags
Benzinga
News
General
From
Benzinga
Why Hoth Therapeutics Stock Is Soaring Today?
January 04, 2022
Tickers
HOTH
Tags
Market News
Biotech
Long Ideas
From
Benzinga
Why Biogen's Alzheimer's drug Aduhelm is so controversial
January 04, 2022
Tags
US: News
Health Insurance
Business News
From
CNBC.com News
Medicare Trying To Determine Coverage Of Biogen's Expensive Alzheimer's Drug: NYT
January 03, 2022
Tickers
BIIB
Tags
BIIB
Market News
Biotech
From
Benzinga
Acadia Slims Nuplazid Label Expansion Application For Alzheimer's Disease Psychosis
December 21, 2021
Tickers
ACAD
Tags
Benzinga
Movers
General
From
Benzinga
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
Tickers
BIIB
Tags
Trading Ideas
BIIB
Alzheimer's disease
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.